Neurobiology of Aging
Volume 29, Issue 5 , Pages 653-660 , May 2008

Presenilins regulate the cellular level of the tumor suppressor PTEN

  • Han Zhang

      Affiliations

    • Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China
    • Both authors contributed equally to this work.
    • ,
  • Runzhong Liu

      Affiliations

    • Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China
    • Both authors contributed equally to this work.
    • ,
  • Ruishan Wang

      Affiliations

    • Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China
    • ,
  • Shuigen Hong

      Affiliations

    • Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China
    • ,
  • Huaxi Xu

      Affiliations

    • Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China
    • Burnham Institute for Medical Research, La Jolla, CA 92037, USA
    • Corresponding Author InformationCorresponding authors at: Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China. Tel.: +86 592 2188568; fax: +86 592 2188528.
    • ,
  • Yun-wu Zhang

      Affiliations

    • Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China
    • Burnham Institute for Medical Research, La Jolla, CA 92037, USA
    • Corresponding Author InformationCorresponding authors at: Institute for Biomedical Research and School of Life Sciences, Xiamen University, 361005 Xiamen, China. Tel.: +86 592 2188568; fax: +86 592 2188528.

Received 14 October 2006 ,Revised 17 November 2006 ,Accepted 28 November 2006.

References 

  1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996;15:6541–6551
  2. Avila J. Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett. 2006;580(12):2922–2927
  3. Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, Gama-Sosa M, et al. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 2004;23:2586–2596
  4. Beglopoulos V, Sun X, Saura CA, Lemere CA, Kim RD, Shen J. Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J. Biol. Chem. 2004;279(45):46907–46914
  5. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta 1-42/1-40 ratio in vitro and in vivo. Neuron. 1996;17(5):1005–1013
  6. Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, et al. Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 1990;87(15):6003–6006
  7. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 1998;391:387–390
  8. De Strooper B. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron. 2003;38(1):9–12
  9. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 1998;19:348–355
  10. Dominguez DI, Hartmann D, De Strooper B. BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease. Neurodegener. Dis. 2004;1(4–5):168–174
  11. Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, St. George-Hyslop P, Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 1999;13:2801–2810
  12. Fraser MM, Zhu X, Kwon CH, Uhlmann EJ, Gutmann DH, Baker SJ. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res. 2004;64:7773–7779
  13. Golde TE. The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol. 2005;15:84–87
  14. Greenfield JP, Gross RS, Gouras GK, Xu H. Cellular and molecular basis of beta-amyloid precursor protein metabolism. Front Biosci. 2000;5:D72–D83
  15. Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, et al. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem. 2005;93:105–117
  16. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356
  17. Kang DE, Yoon IS, Repetto E, Busse T, Yermian N, Ie L, et al. Presenilins mediate phosphatidylinositol 3-kinase/AKT and ERK activation via select signaling receptors. Selectivity of PS2 in platelet-derived growth factor signalling. J. Biol. Chem. 2005;280:31537–31547
  18. Kim SH, Leem JY, Lah JJ, Slunt HH, Levey AI, Thinakaran G, et al. Multiple Effects of Aspartate Mutant Presenilin 1 on the Processing and Trafficking of Amyloid Precursor Protein. J. Biol. Chem. 2001;276:43343–43350
  19. Ksiezak-Reding H, Pyo HK, Feinstein B, Pasinetti GM. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. Biochim. Biophys. Acta. 2003;1639:159–168
  20. Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, et al. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat. Genet. 2001;29:404–411
  21. Leem JY, Saura CA, Pietrzik C, Christianson J, Wanamaker C, King LT, et al. A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 2002;11:64–82
  22. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973–977
  23. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle. 2003;2(4):339–345
  24. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 1998;273:13375–13378
  25. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, et al. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 1992;314:315–321
  26. Marambaud P, Robakis NK. Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. Genes Brain Behav. 2005;4(3):134–146
  27. Marino S, Krimpenfort P, Leung C, van der Korput HA, Trapman J, Camenisch I, et al. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development. 2002;129(14):3513–3522
  28. Martin D, Salinas M, Lopez-Valdaliso R, Serrano E, Recuero M, Cuadrado A. Effect of the Alzheimer amyloid fragment Aβ(25–35) on Akt/PKB kinase and survival of PC12 cells. J. Neurochem. 2001;78:1000–1008
  29. Matsuo ES, Shin RW, Van Billingsley ML, deVoorde A, O’Connor M, Trojanowski JQ, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 1994;13:989–1002
  30. Mulholland DJ, Dedhar S, Wu H, Nelson CC. PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene. 2006;25(3):329–337
  31. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. U.S.A. 1998;95:13513–13518
  32. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, et al. Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron. 2005;46(4):541–554
  33. Pei JJ, Khatoon S, An WL, Nordlinder M, Tanaka T, Braak H, et al. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol. (Berl.). 2003;105:381–392
  34. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. U.S.A. 1999;96:1563–1568
  35. Rickle A, Bogdanovic N, Volkman I, Winblad B, Ravid R, Cowburn RF. Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport. 2004;15:955–959
  36. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376:775–778
  37. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron. 2004;42(1):23–36
  38. Selkoe D, Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu. Rev. Neurosci. 2003;26:565–597
  39. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 1997;89(4):629–639
  40. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375:754–760
  41. Sisodia SS, Kim SH, Thinakaran G. Function and dysfunction of the presenilins. Am. J. Hum. Genet. 1999;65:7–12
  42. Stein TD, Johnson JA. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 2002;22:7380–7388
  43. Stiles B, Groszer M, Wang S, Jiao J, Wu H. PTENless means more. Dev. Biol. 2004;273:175–184
  44. Sulis ML, Parsons R. PTEN: from pathology to biology. Trends Cell Biol. 2003;13:478–483
  45. Thinakaran G, Regard JB, Bouton CM, Harris CL, Price DL, Borchelt DR, et al. Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 1998;4(6):438–453
  46. Thinakaran G, Parent AT. Identification of the role of presenilins beyond Alzheimer's disease. Pharm. Res. 2004;50:411–418
  47. Trojanowski JQ, Schmidt ML, Shin RW, Bramblett GT, Rao D, Lee VM. Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 1993;3:45–54
  48. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304(5674):1158–1160
  49. Vetrivel KS, Zhang YW, Xu H, Thinakaran G. Pathological and physiological functions of presenilins. Mol. Neurodegener. 2006;1:4
  50. Wang R, Zhang YW, Sun P, Liu R, Zhang X, Zhang X, et al. Transcriptional regulation of PEN-2, a key component of the gamma-secretase complex, by CREB. Mol. Cell. Biol. 2006;26(4):1347–1354
  51. Wang R, Zhang YW, Zhang X, Liu R, Zhang X, Hong S, et al. Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J. 2006;20(8):1275–1277
  52. Wei W, Wang X, Kusiak JW. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 2002;277:17649–17656
  53. Weihl CC, Ghadge GD, Kennedy SG, Hay N, Miller RJ, Roos RP. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J. Neurosci. 1999;19:5360–5369
  54. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 1997;387(6630):288–292
  55. Xia X, Qian S, Soriano S, Wu Y, Fletcher AM, Wang XJ, et al. Loss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2001;98(19):10863–10868
  56. Xu H, Sweeney D, Wang R, Thinakaran G, Lo AC, Sisodia SS, et al. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl. Acad. Sci. U.S.A. 1997;94(8):3748–3752
  57. Zhang X, Li F, Bulloj A, Zhang YW, Tong G, Zhang Z, et al. Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules. FASEB J. 2006;20(8):1272–1274
  58. Zhang X, Zhang YW, Liu S, Bulloj A, Tong GG, Zhang Z, et al. Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau. Mol. Neurodegener. 2006;1:7
  59. Zhang YW, Luo WJ, Wang H, Lin P, Vetrivel KS, Liao F, et al. Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components. J. Biol. Chem. 2005;280(17):17020–17026

PII: S0197-4580(06)00442-8

doi: 10.1016/j.neurobiolaging.2006.11.020

Neurobiology of Aging
Volume 29, Issue 5 , Pages 653-660 , May 2008

Article Tools

* Image Usage & Resolution